Drug Bioanalysis Services
Creative Biolabs facilitates an expansive portfolio of bioanalytical testing services structured to provide precise quantification of pharmaceutical candidates across a diverse range of biological matrices. These services encompass the systematic development, optimization, and rigorous validation of analytical assays for both low-molecular-weight entities and complex biologics. By integrating high-resolution mass spectrometry with automated ligand-binding platforms, the organization provides the research community with data characterized by exceptional sensitivity and analytical specificity.
Drug Bioanalysis Empowering Drug Discovery and Development
Drug discovery and development are complex processes that require meticulous attention to detail and precise analysis at every stage. Bioanalysis services play a crucial role in providing accurate and reliable data for pharmacokinetic and pharmacodynamic characterization of small molecule drugs as well as biomacromolecule drugs, ultimately leading to the market authorization of safe and efficacious drugs. With more than 20 years of industry experience, Creative Biolabs provides comprehensive drug bioanalysis services to support drug discovery and development for pharmaceutical companies.
Explore strategic bioanalytical collaborative opportunities - Schedule a technical consultation.
Fig.1 Flowchart of bioanalytical methods for quantification and pharmacokinetic analyses. 1
What We Can Offer
Creative Biolabs offers a comprehensive range of drug bioanalysis services to meet the diverse needs of biotechnology and pharmaceutical companies. From developing new tests for early detection to validating tests according to international guidelines, Creative Biolabs offers a full suite of analytical support at every stage of drug development.
Creative Biolabs excels in developing and optimizing bioanalytical methods for different types of drugs (such as small-molecule drugs and large-molecule drugs), utilizing multiple technology platforms such as mass spectrometry (LC-MS/MS). By tailoring the approach to suit the unique characteristics of each drug candidate, we ensure accurate and sensitive detection.
At Creative Biolabs, we are committed to providing the following services:
Small-Molecule Drug Bioanalysis Service
We provide sensitive quantification of chemical entities and metabolites, ensuring robust pharmacokinetic data through meticulous method validation and high-throughput sample processing.
Learn More →Large-Molecule Drug Bioanalysis Service
Our comprehensive platform utilizes ultra-sensitive ligand-binding assays and hybrid LC-MS/MS to quantify biologics, including monoclonal antibodies and ADCs, ensuring precise pharmacokinetic characterization for complex therapeutic modalities.
Learn More →LC-MS-based Bioanalysis Service
This specialized service leverages high-resolution liquid chromatography-mass spectrometry to deliver simultaneous, high-throughput quantification of diverse analytes, offering exceptional selectivity and sensitivity for complex discovery-stage biological samples.
Learn More →Immunoassay Service
This service utilizes high-sensitivity ELISA, MSD, and chemiluminescence platforms for precise protein quantification, enabling the detection of drug candidates and biomarkers within complex research matrices through robust ligand-binding techniques.
Learn More →How Creative Biolabs' service Can Assist Your Projects
Why Choose Us?
At Creative Biolabs, our drug bioanalysis service offers cutting-edge solutions tailored to meet the unique needs of pharmaceutical and biotechnology companies in drug discovery and development. With extensive expertise in bioanalytical techniques and drug development, our team is committed to providing comprehensive and accurate services to support the advancement of therapeutic research.
| • Customized Method Development | • Expert Method Transfer and Cross-Validation | • High Throughput Analysis | |
| • Comprehensive Analytical and Regulatory Support | • Dedicated Team of Professionals | ||
Request formal technical specifications for bespoke bioanalytical methodologies - Engage with our scientific experts.
Customer Reviews
-
Scientific Confidence
The progression from initial discovery through to formal validation was executed with exceptional continuity. Furthermore, the stringent data integrity protocols maintained by Creative Biolabs ensured that our internal reviews were conducted with total transparency and objective certainty. – S**h L*n. -
Complex Modality Expertise
Determining the drug-to-antibody ratio (DAR) for a novel antibody-drug conjugate (ADC) constituted a substantial analytical challenge. However, the utilization of Creative Biolabs' hybrid high-resolution mass spectrometry (HRMS) methodology provided the precise structural characterization essential for proceeding to subsequent investigative stages. - Prof. R*rt H.
FAQs
How do you handle non-specific binding (NSB) for hydrophobic peptides?
To mitigate non-specific binding, our laboratory employs specialized anti-adsorption chemical additives alongside low-protein-binding plasticware during sample preparation and storage phases. This comprehensive approach ensures accurate recovery and maintains high analytical precision for hydrophobic analytes.
How do you ensure data integrity?
All research initiatives are conducted within our high-specification facilities, where data management follows stringent internal protocols. This rigorous framework guarantees complete traceability, unalterable audit trails, and the consistent reproducibility of all experimental findings.
Related Services
Affinity Measurement Service
This service utilizes SPR and BLI technologies to provide precise kinetic measurements, including association and dissociation rates. It delivers critical quantitative insights into molecular interactions to optimize therapeutic candidate selection.
Learn More →In Vitro ADME Screening Service
This service provides essential metabolic and permeability data through comprehensive screening of absorption, distribution, metabolism, and excretion. It enables researchers to identify favorable candidates early in the drug discovery pipeline.
Learn More →How to Contact Us
Working with Creative Biolabs, we will provide biotech and pharmaceutical companies with a strong strategic advantage in navigating drug development. Creative Biolabs places a high value on methodological accuracy, compliance, and comprehensive data interpretation, and is a trusted partner to support the development of innovative therapies from discovery to market authorization. For more details about our drug bioanalysis services, please feel free to get in touch with us.
Reference
- Khan, R M Naseer et al. "Recent Advances in Bioanalytical Methods for Quantification and Pharmacokinetic Analyses of Antibody-Drug Conjugates." The AAPS journal vol. 27,6 138. 4 Sep. 2025. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1208/s12248-025-01115-9
Download our brochure